The mRNA levels of IL-17 in peripheral blood were significantly higher in NSCLC patients (68.98 ± 6.66) than in healthy controls (6.59 ± 0.73, P < 0.0001) (Figure 2(b)). Here, IL17A is linked to non-small cell lung carcinoma.